The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe Biden back in 2022: the Inflation Reduction Act, which allowed the CMS to negotiate the price of 15 drugs per year with pharmaceutical companies for the first time.
Trump admin unveils Medicare negotiated price cuts for 15 drugs
view original post